Latest Asia Pacific News

RLF AgTech has secured exclusive rights to distribute AXIOMA Biologicals’ advanced biostimulant products across Australia, China, and Asia, marking a strategic move into the biologicals market segment.

Harvest Technology Group reports it is one year ahead of its 3-Year Pathway to Profit plan, forecasting a significant reduction in EBITDA loss for FY25 and unveiling plans for its AI-powered NEON platform launch in 1H26.

Hazer Group unveils a strategic alliance with engineering giant KBR to fast-track its low-cost clean hydrogen technology, targeting major global markets with a capex-lite licensing model.

NH3 Clean Energy reports strong Pre-FEED results for its WAH2 clean ammonia project, highlighting robust economics and strategic partnerships while facing key risks around gas supply and funding.

Invion Limited launches a Loyalty Option entitlement offer aimed at raising up to $16 million to support its advancing cancer clinical trials, including a promising anogenital cancer study with Peter MacCallum Cancer Centre.

Terra Metals has raised $4 million through a strategic placement, attracting heavyweight investors to accelerate exploration at its Dante Project in Western Australia.

Cochlear Limited has lowered its FY25 earnings guidance due to slower-than-expected sales growth and a sharper decline in Services revenue. Despite this, implant unit growth remains on track, driven by emerging markets.

Austin Engineering has raised its FY25 revenue guidance to $370 million, driven by strong growth in the Americas, but has lowered its EBIT forecast due to operational challenges in Chile.

FinTech HQ Pty Ltd, the second largest shareholder in NSX Limited, has declared its intention to support the proposed acquisition by the Canadian Securities Exchange, pending no better offers emerge.

NEXTDC has increased its contracted utilisation by 16MW to 244MW, driven by new hyperscale customer contracts at its Kuala Lumpur data centre, KL1, set to launch in early 2026.

icetana AI has forged a multi-year strategic partnership with SoftBank Robotics Group, including a A$1.87 million equity investment and exclusive distribution rights in Japan, setting the stage for accelerated growth and innovation in the Asia-Pacific region.

Firebrick Pharma has unexpectedly withdrawn its planned share placement, raising questions about its capital strategy amid ongoing product launches.